The French National Authority for Health (HAS) published new set of decisions about add-on reimbursement for medical devices in February

07

Mar 2018

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 28 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in February.

Four decisions were released for cardiovascular devices:

Sixteen decisions were published for devices for arthroplasty:

  • GYROS, double mobility cementless cup (application for registration, approved)
  • FIXA 3P DUPLEX , dual-mobility cementless cup (application for registration, rejected due to insufficient expected benefit)
  • FIXA DUPLEX, dual-mobility cemented cup (application for registration, rejected due to insufficient expected benefit)
  • FIXA DUPLEX, dual-mobility cementless cup (application for registration, rejected due to insufficient expected benefit)
  • LIBERTY SC - LIBERTY T, dual-mobility cementless cup (application for registration, approved)
  • LIBERTY AC, dual-mobility cemented cup (application for registration, approved)
  • ADES et ADES PLUS, dual-mobility cementless cup (application for registration, approved)
  • ADES,  dual-mobility cemented cup (application for registration, approved)
  • INTEGRA DE REPRISE, dual-mobility cementless cup (application for registration, approved)
  • INTEGRA, dual-mobility cementless cup (application for registration, rejected)
  • QUATTRO CIM, dual-mobility cemented cup (application for registration, approved)
  • QUATTRO HAP, dual-mobility cementless cup (application for registration, approved)
  • TREGOR – TREGOR, dual-mobility cementless cup (application for registration, approved)
  • TREGOR MEDIAL CUP, dual-mobility cemented cup (application for registration, approved)
  • NOVAE, dual-mobility cementless cup (application for registration, approved for 28 mm diameter, rejected for 32 mm)
  • NOVAE STICK, dual mobility cemented cup (application for registration, approved for 28 mm; rejected for 32 mm)

Two decisions were released for porous high-density polyethylene implants for facial and cranial reconstruction:

  • OMNIPORE, (application for registration, rejected due to insufficient expected benefit)
  • OMNIPORE (standard), (application for registration, rejected due to insufficient expected benefit)

Five decisions were for other devices:

  • ALBER VIAPLUS V12, wheelchair add-on electric propulsion system (request for registration, approved)
  • INVACARE COLIBRI OUTDOOR, modular electric scooter (application for registration, approved)
  • LARYVOX FAHL, respiratory prostheses for total laryngectomy with or without phonatory implants (application for registration, approved)
  • PONTO, osteo-integrated prosthesis (request for delisting, approved)
  • RONDO 2, audio processor for cochlear implant system (application for registration, approved)
  • RE-FLEX, prosthetic foot (III energy class) (renewal of registration, approved)

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more